Sionna Therapeutics (SION) Payables (2024 - 2026)
Quarterly results put Payables at $2.1 million for Q1 2026, down 57.98% from a year ago — trailing twelve months through Mar 2026 was $2.1 million (down 57.98% YoY), and the annual figure for FY2025 was $769000.0, down 35.16%.
Sionna Therapeutics has reported Payables over the past 3 years, most recently at $2.1 million for Q1 2026.
- Payables reached $2.1 million in Q1 2026 per SION's latest filing, up from $769000.0 in the prior quarter.
- Across five years, Payables topped out at $5.0 million in Q1 2025 and bottomed at $769000.0 in Q4 2025.
- Median Payables over the past 3 years was $1.3 million (2024), compared with a mean of $1.9 million.
- The largest annual shift saw Payables tumbled 35.16% in 2025 before it plummeted 57.98% in 2026.
- Over 3 years, Payables stood at $1.2 million in 2024, then crashed by 35.16% to $769000.0 in 2025, then soared by 174.25% to $2.1 million in 2026.
- Business Quant data shows Payables for SION at $2.1 million in Q1 2026, $769000.0 in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 769,000.00 |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 914,000.00 |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 1.19 Mn |